Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement of Operations (Unaudited)

v3.22.1
Condensed Statement of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Apr. 03, 2022
Mar. 31, 2021
Operating Expenses:    
Cost of revenue $ 515 $ 1,631
Research and development 12,731 5,589
Selling, general and administrative 11,869 4,161
Total operating expenses 25,115 11,381
Loss from operations (25,115) (11,381)
Other income (expense):    
Changes in fair value of convertible preferred stock warrants and common stock warrants 67,800 (4,781)
Other income (expense), net 22 (3)
Total other income (expense), net 67,822 (4,784)
Net income (loss) $ 42,707 $ (16,165)
Net income (loss) per share, basic $ 0.28 $ (0.17)
Weighted average number of common shares outstanding, basic 151,648,439 95,816,889
Net loss per share, diluted $ (0.16) $ (0.17)
Weighted average number of common shares outstanding, diluted 153,338,462 95,816,889